These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 20888177

  • 1. Application of artificial neural networks in estimating predictive factors and therapeutic efficacy in idiopathic membranous nephropathy.
    Naumovic R, Furuncic D, Jovanovic D, Stosovic M, Basta-Jovanovic G, Lezaic V.
    Biomed Pharmacother; 2010 Nov; 64(9):633-8. PubMed ID: 20888177
    [Abstract] [Full Text] [Related]

  • 2. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 4. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C, Passerini P.
    Clin Nephrol; 1991 May; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
    Idasiak-Piechocka I, Oko A, Łochyńska-Bielecka K, Skrobańska B.
    Kidney Blood Press Res; 2009 May; 32(4):263-7. PubMed ID: 19776643
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
    N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
    [Abstract] [Full Text] [Related]

  • 8. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
    Ponticelli C, Zucchelli P, Passerini P, Cesana B.
    N Engl J Med; 1992 Aug 27; 327(9):599-603. PubMed ID: 1640953
    [Abstract] [Full Text] [Related]

  • 9. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
    Hofstra JM, Wetzels JF.
    Nephrol Dial Transplant; 2008 Nov 27; 23(11):3534-8. PubMed ID: 18559961
    [Abstract] [Full Text] [Related]

  • 10. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 27; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 11. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 27; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Jan 27; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 13. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R, Hn HK, Kumar V, Nada R, Yadav AK, Goyal A, Kumar V, Rathi M, Jha V, Gupta KL, Sakhuja V, Kohli HS.
    Nephrology (Carlton); 2016 Feb 27; 21(2):139-46. PubMed ID: 26205759
    [Abstract] [Full Text] [Related]

  • 14. [Prognosis and treatment of membranous glomerulonephritis-a 5-year prospective study].
    Covic A, Căruntu ID, Marian D, Volovăţ C, Ghiciuc C, Costin C, Florea L, Cotuţiu C, Covic M.
    Rev Med Chir Soc Med Nat Iasi; 2000 Feb 27; 104(2):63-74. PubMed ID: 12089993
    [Abstract] [Full Text] [Related]

  • 15. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH, Grcevska L.
    Am J Kidney Dis; 1999 Nov 27; 34(5):911-7. PubMed ID: 10561149
    [Abstract] [Full Text] [Related]

  • 16. [Clinical outcome assessment of membranous nephropathy].
    Kumagai T, Shimizu H, Nishi T, Mise N, Tagawa H, Sugimoto T.
    Nihon Jinzo Gakkai Shi; 2005 Nov 27; 47(8):870-5. PubMed ID: 16408431
    [Abstract] [Full Text] [Related]

  • 17. Effective treatment administration of cyclophosphamide in membranous nephropathy.
    Dede F, Ayili D, Sahiner S.
    J Nephrol; 2008 Nov 27; 21(4):560-5. PubMed ID: 18651546
    [Abstract] [Full Text] [Related]

  • 18. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 27; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG, Tishkov I, Nikolov D.
    Nephrol Dial Transplant; 1994 Feb 27; 9(2):138-43. PubMed ID: 8190328
    [Abstract] [Full Text] [Related]

  • 20. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008 Feb 27; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.